share_log

和黃醫藥:發行人剛在本網站英文版面發布一項公告,相應中文版本或會/或不會在本版面發布。

HUTCHMED: Vesting of awards under the Long Term Incentive Plan

Hong Kong Stock Exchange ·  Apr 22 04:33
Summary by Moomoo AI
和黄医药(股份代號:00013.HK)近日在其官方網站英文版面發布了一項公告。該公告的中文版本可能不會在同一版面發布。和黄医药是一家專注於創新藥物開發的生物醫藥公司,其公告內容對投資者和市場參與者具有重要意義。然而,具體公告詳情尚未提供,投資者需關注後續信息更新。
和黄医药(股份代號:00013.HK)近日在其官方網站英文版面發布了一項公告。該公告的中文版本可能不會在同一版面發布。和黄医药是一家專注於創新藥物開發的生物醫藥公司,其公告內容對投資者和市場參與者具有重要意義。然而,具體公告詳情尚未提供,投資者需關注後續信息更新。
HUANG PHARMACEUTICALS (STOCK CODE: 00013.HK) RECENTLY PUBLISHED AN ANNOUNCEMENT IN ENGLISH ON ITS OFFICIAL WEBSITE. The Chinese version of this announcement may not be published in the same version. Huanghuang Pharmaceuticals is a biopharmaceutical company focused on innovative drug development and its announcements are important to investors and market participants. However, specific details of the announcement have not yet been provided and investors should be attentive to subsequent information updates.
HUANG PHARMACEUTICALS (STOCK CODE: 00013.HK) RECENTLY PUBLISHED AN ANNOUNCEMENT IN ENGLISH ON ITS OFFICIAL WEBSITE. The Chinese version of this announcement may not be published in the same version. Huanghuang Pharmaceuticals is a biopharmaceutical company focused on innovative drug development and its announcements are important to investors and market participants. However, specific details of the announcement have not yet been provided and investors should be attentive to subsequent information updates.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more